Edition:
United States

Biotechnology & Medical Research

Galapagos 2016 net result turns to profit of EUR 54.0 mln

Galapagos NV : 2016 revenues increased by 91.0 million euros ($96.41 million) to 151.6 million euros . 2016 operating loss reduced by 77.9 million euros to 11.5 euros million . 2016 net profit of 54.0 million euros, compared to a net loss of 118.4 million euros in 2015 . 2016 cash balance increased...

3:49am EST

Shanghai RAAS Blood Products' prelim 2016 net profit rises 11.8 pct y/y

Shanghai RAAS Blood Products Co Ltd :Says preliminary 2016 net profit up 11.8 percent y/y at 1.6 billion yuan ($232.85 million).

3:49am EST

Oxford biomedica says Trovax shown to induce beneficial anti-tumour immune responses

Oxford Biomedica Plc : Cyclophosphamide and Trovax independently shown to induce highly beneficial anti-tumour immune responses .Both drugs resulting in significantly prolonged survival of advanced colorectal cancer patients.

2:28am EST

Pledpharma Q4 net loss widens to SEK 11.5 million

Pledpharma AB (publ) :Q4 net loss 11.5 million Swedish crowns ($1.3 million) versus loss 8.8 million crowns year ago.

2:00am EST

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.